Patents Assigned to Ardea Biociences, Inc.
  • Publication number: 20130059868
    Abstract: Sodium 2-(5-bromo-4-(4-cyclopropyl-naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate is described. In addition, pharmaceutical compositions and uses such compositions for the treatment of a variety of diseases and conditions.
    Type: Application
    Filed: March 29, 2011
    Publication date: March 7, 2013
    Applicant: Ardea Biociences, Inc.
    Inventors: Jeffrey Miner, Jean-Luc Girardet, Barry D. Quart